Conversion to sirolimus‐based immunosuppression in maintenance liver transplantation patients
Isabelle Morard, Jérôme Dumortier, Laurent Spahr, Antoine Hadengue, Pietro Majno, Philippe Morel, Gilles Mentha, Emiliano Giostra – 24 April 2007 – Sirolimus (SRL) has been proposed to replace calcineurin inhibitors (CNI) in case of CNI‐induced toxicity. The aim of this study was to evaluate the efficacy and safety of conversion from CNI to SRL in maintenance liver transplantation (LT) patients. Between 2002 and 2006, conversion was performed in 48 patients (17 female, 31 male; mean age 57 ± 10 yr) after a median delay of 19.4 months (range 0.2–173 months) after LT.